Page last updated: 2024-08-24

imiquimod and Hepatitis B

imiquimod has been researched along with Hepatitis B in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Cheung, KS; Hung, IF; Ko, KL; Lam, YF; Leung, WK	1
Chan, KH; Chan, TM; Hung, IF; Kochba, E; Lau, JY; Levin, Y; Lui, SL; Tang, SC; To, KK; Yap, DY; Yip, TP; Yuen, KY; Yuen, MF; Zhang, RR	1
Alonso, MJ; Díaz-Freitas, B; González-Fernández, Á; Peleteiro, M; Sanchez, A; Vicente, S	1
Boland, GJ; Roukens, AH; van Dissel, JT; Verduyn, W; Visser, LG; Vossen, AC	1

Trials

3 trial(s) available for imiquimod and Hepatitis B

Article	Year
Clinical trial: intra dermal hepatitis B vaccination with topical imiquimod versus intra muscular hepatitis B vaccination in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:2 Topics: Adult; Chronic Disease; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Imiquimod; Inflammatory Bowel Diseases; Injections, Intradermal; Injections, Intramuscular; Male; Vaccination	2022
A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021, 07-15, Volume: 73, Issue:2 Topics: Adult; Hepatitis B; Hepatitis B Vaccines; Humans; Imiquimod; Injections, Intradermal; Injections, Intramuscular; Renal Dialysis; Toll-Like Receptor 7; Vaccination	2021
Intradermal hepatitis B vaccination in non-responders after topical application of imiquimod (Aldara). Vaccine, 2010, Jun-11, Volume: 28, Issue:26 Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antibody Affinity; Antibody Formation; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; HLA Antigens; Humans; Imiquimod; Immunity, Humoral; Immunization, Secondary; Injections, Intradermal; Male; Middle Aged; Young Adult	2010

Other Studies

1 other study(ies) available for imiquimod and Hepatitis B

Article	Year
Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy. Journal of controlled release : official journal of the Controlled Release Society, 2013, Dec-28, Volume: 172, Issue:3 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cell Line; Chitosan; Complement Activation; Female; Hepatitis B; Hepatitis B Surface Antigens; Imiquimod; Macrophages; Mice; Mice, Inbred BALB C; Nanocapsules; Toll-Like Receptor 7; Vaccination	2013

Article

Year

Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.

Journal of controlled release : official journal of the Controlled Release Society, 2013, Dec-28, Volume: 172, Issue:3

Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Cell Line; Chitosan; Complement Activation; Female; Hepatitis B; Hepatitis B Surface Antigens; Imiquimod; Macrophages; Mice; Mice, Inbred BALB C; Nanocapsules; Toll-Like Receptor 7; Vaccination

2013